← All organizations

PaxVax, Inc.

For profitWebsite ↗

Also known as: PaxVax, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 15, 2019

Acquired by Emergent BioSolutions on Oct 1, 2018

Timeline

2000s

Jul 1, 2006
PaxVax, Inc.— Founded

2010s

Oct 1, 2018
Emergent BioSolutions— Acquired By

Drugs by trial phase (13 distinct, 13 trials)

Phase 4 (1 own, 0 via acquisition)

cholera vaccine

Phase 2 (3 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT03992872Lead sponsorPhase 2Oct 15, 2019
NCT03483961Study directorPhase 2Apr 18, 2018
NCT03483961Lead sponsorPhase 2Apr 18, 2018
NCT03220737Lead sponsorPhase 4Jul 21, 2017
NCT03220737Study directorPhase 4Jul 21, 2017
NCT03160339Lead sponsorPhase 1May 1, 2017
NCT02771730Lead sponsorPhase 1Mar 1, 2015
NCT02145377CollaboratorPhase 2Jul 1, 2014
NCT02094586Lead sponsorPhase 3May 1, 2014
NCT02100631Lead sponsorPhase 3May 1, 2014
NCT01989533CollaboratorPhase 1Oct 30, 2013
NCT01979406Lead sponsorPhase 1Oct 1, 2013
NCT01979406Study directorPhase 1Oct 1, 2013
NCT01979406Overall official - principal investigatorPhase 1Oct 1, 2013
NCT01895855Lead sponsorPhase 3Sep 1, 2013

Details

Founded: Redwood, CA, US Jul 1, 2006
Last known activity: Oct 15, 2019